Table 3.
Results of prognostic factors related to stability
| n | % | ||
| Stability | |||
| Prior to RT | 72 | 54 | |
| 3 months after RT | 96 | 61 | |
| 6 months after RT | 107 | 68 | |
| General | |||
| p value | |||
| Age | 0.27 | ||
| KPS | 0.47 | ||
| Histology | 0.90 | ||
| Number of metastases (1 vs. > 1) | 0.27 | ||
| Area (thoracic vs. lumbar spine) | 0.97 | ||
| Hormone receptor (positive vs. negative) | 0.18 | ||
| Therapy | |||
| Overall dose | 0.12 | ||
| Therapy within 1 year before RT | |||
| Chemotherapy (yes vs. no) | 0.90 | ||
| Hormone therapy (yes vs. no) | 0.12 | ||
| Bisphosphonates (yes vs. no) | 0.62 | ||
| Therapy after RT | |||
| Chemotherapy (yes vs. no) | 0.21 | ||
| Hormone therapy (yes vs. no) | 0.88 | ||
| Bisphosphonates (yes vs. no) | 0.36 | ||